Multiple myeloma, version 2.2024, NCCN Clinical Practice Guidelines in Oncology Guidelines
| Authors: | Kumar, S. K.; Callander, N. S.; Adekola, K.; Anderson, L. D.; Baljevic, M.; Baz, R.; Campagnaro, E.; Castillo, J. J.; Costello, C.; D'Angelo, C.; Devarakonda, S.; Elsedawy, N.; Garfall, A.; Godby, K.; Hillengass, J.; Holmberg, L.; Htut, M.; Huff, C. A.; Hultcrantz, M.; Kang, Y.; Larson, S.; Lee, H. C.; Liedtke, M.; Martin, T.; Omel, J.; Robinson, T.; Rosenberg, A.; Sborov, D.; Schroeder, M. A.; Sherbenou, D.; Suvannasankha, A.; Valent, J.; Varshavsky-Yanovsky, A. N.; Kumar, R.; Snedeker, J. |
| Title: | Multiple myeloma, version 2.2024, NCCN Clinical Practice Guidelines in Oncology |
| Abstract: | The treatment of relapsed/refractory multiple myeloma (MM) has evolved to include several new options. These include new combinations with second generation proteasome inhibitors (PI); second generation immunomodulators, monoclonal antibodies, CAR T cells, bispecific antibodies, selinexor, venetoclax, and many others. Most patients with MM undergo several cycles of remissions and relapse, and therefore need multiple lines of combination therapies. Selecting treatment options for relapsed/refractory MM requires consideration of resistance status to specific classes, and patient-specific factors such as age and other comorbidities should be considered. The NCCN Guidelines for MM provide a framework on which to base decisions regarding workup, treatment, and follow-up of newly diagnosed and previously treated MM. This manuscript outlines the recommendations from NCCN Guidelines for MM specific to relapsed/refractory disease. |
| Keywords: | antineoplastic agent; multiple myeloma; neoplasm recurrence, local; antineoplastic combined chemotherapy protocols; oncology; monoclonal antibody; antibodies, monoclonal; tumor recurrence; medical oncology; humans; human |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 21 |
| Issue: | 12 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2023-12-01 |
| Start Page: | 1281 |
| End Page: | 1301 |
| Language: | English |
| DOI: | 10.6004/jnccn.2023.0061 |
| PUBMED: | 38081133 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
